We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · September 27, 2020

Switch Maintenance Chemotherapy vs Observation After Carboplatin and Weekly Paclitaxel Doublet Chemotherapy in Elderly Patients With Advanced NSCLC

European Journal of Cancer

 

Additional Info

European Journal of Cancer
Switch Maintenance Chemotherapy Versus Observation After Carboplatin and Weekly Paclitaxel Doublet Chemotherapy in Elderly Patients With Advanced Non-Small Cell Lung Cancer: IFCT-1201 MODEL Trial
Eur. J. Cancer 2020 Sep 05;138(xx)193-201, E Quoix, C Audigier-Valette, A Lavolé, O Molinier, V Westeel, F Barlesi, J Le Treut, E Pichon, J Dauba, J Otto, L Moreau, J Madelaine, P Dumont, J Margery, D Debieuvre, PA Renault, JL Pujol, A Langlais, F Morin, D Moro-Sibilot, PJ Souquet

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading